Castleview Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-59
| Closed | -$42.2K | – | 468 |
|
|
2024
Q4 | $42.2K | Hold |
59
| – | – | 0.02% | 361 |
|
|
2024
Q3 | $62K | Hold |
59
| – | – | 0.04% | 301 |
|
|
2024
Q2 | $62K | Hold |
59
| – | – | 0.04% | 309 |
|
|
2024
Q1 | $56.8K | Hold |
59
| – | – | 0.03% | 337 |
|
|
2023
Q4 | $51.8K | Hold |
59
| – | – | 0.04% | 289 |
|
|
2023
Q3 | $48.6K | Hold |
59
| – | – | 0.04% | 259 |
|
|
2023
Q2 | $42.4K | Hold |
59
| – | – | 0.04% | 273 |
|
|
2023
Q1 | $48.5K | Hold |
59
| – | – | 0.04% | 268 |
|
|
2022
Q4 | $42.6K | Hold |
59
| – | – | 0.04% | 244 |
|
|
2022
Q3 | $41K | Sell |
59
-3,221
| -98% | -$2.24M | 0.04% | 275 |
|
|
2022
Q2 | $61.5K | Buy |
3,280
+3,221
| +5,459% | +$60.4K | 0.05% | 274 |
|
|
2022
Q1 | $41K | Sell |
59
-37,200
| -100% | -$25.9M | 0.03% | 369 |
|
|
2021
Q4 | $59 | Buy |
+37,259
| New | +$59 | ﹤0.01% | 867 |
|
|
2021
Q2 | $33K | Buy |
+59
| New | +$33K | 0.01% | 485 |
|